Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 BNT162b2 mRNA Vaccine in Greek Healthcare Workers

Messenger RNA vaccines against SARS-CoV-2

(2021) Eric J. Topol   CELL

COVID-19 vaccines: where we stand and challenges ahead

(2021) Guido Forni et al.   CELL DEATH AND DIFFERENTIATION

Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design

(2021) Xuhua Xia   Viruses-Basel

mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach

(2021) Aleena Banerji et al.   Journal of Allergy and Clinical Immunology-In Practice

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021

(2021) Kamal Abu Jabal et al.   Eurosurveillance

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

(2021) Zijun Wang et al.   NATURE

Sex‐based differences in severity and mortality in COVID‐19

(2021) Mustafa Alwani et al.   REVIEWS IN MEDICAL VIROLOGY

Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays

(2021) Anja Dörschug et al.   Diagnostics

Age‐dependent and gender‐dependent antibody responses against SARS‐CoV ‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine

(2021) Evangelos Terpos et al.   AMERICAN JOURNAL OF HEMATOLOGY

Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents

(2021) Jens T Van Praet et al.   CLINICAL INFECTIOUS DISEASES

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

(2021) Ayelet Grupper et al.   Clinical Journal of the American Society of Nephrology

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers

(2021) Ross J. Harris et al.   JOURNAL OF INFECTION

Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2?

(2021) Patrick L Iversen et al.   LANCET INFECTIOUS DISEASES

Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines

(2021) Bogdan Doroftei et al.   Diagnostics

Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination

(2021) Gian Luca Salvagno et al.   Diagnostics

Role of nanotechnology behind the success of mRNA vaccines for COVID-19

(2021) Amit Khurana et al.   Nano Today

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

(2021) Ugur Sahin et al.   NATURE

Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform

(2021) George Mpekoulis et al.   PLoS One

Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China

(2020) Weier Wang et al.   JOURNAL OF MEDICAL VIROLOGY

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

(2020)   Nature Microbiology

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

(2020) Luca Piccoli et al.   CELL

mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection

(2020) Shuqin Xu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

(2020) Gregory A Poland et al.   LANCET